Tine Monberg

6PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 20, 2026
Immune-cytokine signature predicts survival in patients with advanced melanoma treated with oncolytic adenovirus TILT-123 and chemotherapy and IL-2-free adoptive TIL therapy.

|Apr 24, 2026
Tumor Infiltrating Lymphocyte Therapy Combined With PD-1/LAG-3 Inhibition in Patients With Recurrent Platinum-Resistant Ovarian Cancer.

|Mar 05, 2026
Prospective study of patients with immune checkpoint inhibitor-induced hepatitis; characterization of liver injury, outcome of therapy, and management of steroid-unresponsive and steroid-dependent hepatitis.

Rikke Boedker Holmstroem, Ane Soegaard Teisner, Mark Wilhelmus Dirk Sweep

|Dec 21, 2023
LTX-315 and adoptive cell therapy using tumor-infiltrating lymphocytes generate tumor specific T cells in patients with metastatic soft tissue sarcoma.

Morten Nielsen, Tine Monberg, Vibeke Sundvold

|Apr 14, 2023
TIL Therapy: Facts and Hopes.

Tine J Monberg, Troels H Borch, Inge M Svane

Pageof 1

Frequent Collaborators

5 joint publications

Inge Marie Svane

3 joint publications

Marco Donia

2 joint publications

Troels Holz Borch

2 joint publications

Victor Arias